Literature DB >> 34793860

An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues.

Ren Zhang1, Kezhong Zhang2.   

Abstract

In mammals, triglyceride (TG), the main form of lipids for storing and providing energy, is stored in white adipose tissue (WAT) after food intake, while during fasting it is routed to oxidative tissues (heart and skeletal muscle) for energy production, a process referred to as TG partitioning. Lipoprotein lipase (LPL), a rate-limiting enzyme in this fundamental physiological process, hydrolyzes circulating TG to generate free fatty acids that are taken up by peripheral tissues. The postprandial activity of LPL declines in oxidative tissues but rises in WAT, directing TG to WAT; the reverse is true during fasting. However, the molecular mechanism in regulating tissue-specific LPL activity during the fed-fast cycle has not been completely understood. Research on angiopoietin-like (ANGPTL) proteins (A3, A4, and A8) has resulted in an ANGPTL3-4-8 model to explain the TG partitioning between WAT and oxidative tissues. Food intake induces A8 expression in the liver and WAT. Liver A8 activates A3 by forming the A3-8 complex, which is then secreted into the circulation. The A3-8 complex acts in an endocrine manner to inhibit LPL in oxidative tissues. WAT A8 forms the A4-8 complex, which acts locally to block A4's LPL-inhibiting activity. Therefore, the postprandial activity of LPL is low in oxidative tissues but high in WAT, directing circulating TG to WAT. Conversely, during fasting, reduced A8 expression in the liver and WAT disables A3 from inhibiting oxidative-tissue LPL and restores WAT A4's LPL-inhibiting activity, respectively. Thus, the fasting LPL activity is high in oxidative tissues but low in WAT, directing TG to the former. According to the model, we hypothesize that A8 antagonism has the potential to simultaneously reduce TG and increase HDL-cholesterol plasma levels. Future research on A3, A4, and A8 can hopefully provide more insights into human health, disease, and therapeutics.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ANGPTL3; ANGPTL4; ANGPTL8; Endothelial lipase; HDL-cholesterol; Lipoprotein lipase; Triglyceride

Mesh:

Substances:

Year:  2021        PMID: 34793860      PMCID: PMC8760165          DOI: 10.1016/j.plipres.2021.101140

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  117 in total

Review 1.  The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism.

Authors:  R Zechner
Journal:  Curr Opin Lipidol       Date:  1997-04       Impact factor: 4.776

2.  ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia.

Authors:  Daniel Gaudet; Daniel A Gipe; Robert Pordy; Zahid Ahmad; Marina Cuchel; Prediman K Shah; Kuang-Yuh Chyu; William J Sasiela; Kuo-Chen Chan; Diane Brisson; Etienne Khoury; Poulabi Banerjee; Viktoria Gusarova; Jesper Gromada; Neil Stahl; George D Yancopoulos; G Kees Hovingh
Journal:  N Engl J Med       Date:  2017-07-20       Impact factor: 91.245

3.  Coexpression of novel furin-resistant LPL variants with lipase maturation factor 1 enhances LPL secretion and activity.

Authors:  Ming Jing Wu; Anna Wolska; Benjamin S Roberts; Ellis M Pearson; Aspen R Gutgsell; Alan T Remaley; Saskia B Neher
Journal:  J Lipid Res       Date:  2018-10-14       Impact factor: 5.922

Review 4.  Lipoprotein lipase: genetics, lipid uptake, and regulation.

Authors:  Martin Merkel; Robert H Eckel; Ira J Goldberg
Journal:  J Lipid Res       Date:  2002-12       Impact factor: 5.922

5.  ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance.

Authors:  Jorge F Haller; Ivory J Mintah; Lisa M Shihanian; Panayiotis Stevis; David Buckler; Corey A Alexa-Braun; Sandra Kleiner; Serena Banfi; Jonathan C Cohen; Helen H Hobbs; George D Yancopoulos; Andrew J Murphy; Viktoria Gusarova; Jesper Gromada
Journal:  J Lipid Res       Date:  2017-04-15       Impact factor: 5.922

6.  Evinacumab for Homozygous Familial Hypercholesterolemia.

Authors:  Frederick J Raal; Robert S Rosenson; Laurens F Reeskamp; G Kees Hovingh; John J P Kastelein; Paolo Rubba; Shazia Ali; Poulabi Banerjee; Kuo-Chen Chan; Daniel A Gipe; Nagwa Khilla; Robert Pordy; David M Weinreich; George D Yancopoulos; Yi Zhang; Daniel Gaudet
Journal:  N Engl J Med       Date:  2020-08-20       Impact factor: 91.245

Review 7.  Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis.

Authors:  I J Goldberg
Journal:  J Lipid Res       Date:  1996-04       Impact factor: 5.922

8.  Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks.

Authors:  Gina M Peloso; Paul L Auer; Joshua C Bis; Arend Voorman; Alanna C Morrison; Nathan O Stitziel; Jennifer A Brody; Sumeet A Khetarpal; Jacy R Crosby; Myriam Fornage; Aaron Isaacs; Johanna Jakobsdottir; Mary F Feitosa; Gail Davies; Jennifer E Huffman; Ani Manichaikul; Brian Davis; Kurt Lohman; Aron Y Joon; Albert V Smith; Megan L Grove; Paolo Zanoni; Valeska Redon; Serkalem Demissie; Kim Lawson; Ulrike Peters; Christopher Carlson; Rebecca D Jackson; Kelli K Ryckman; Rachel H Mackey; Jennifer G Robinson; David S Siscovick; Pamela J Schreiner; Josyf C Mychaleckyj; James S Pankow; Albert Hofman; Andre G Uitterlinden; Tamara B Harris; Kent D Taylor; Jeanette M Stafford; Lindsay M Reynolds; Riccardo E Marioni; Abbas Dehghan; Oscar H Franco; Aniruddh P Patel; Yingchang Lu; George Hindy; Omri Gottesman; Erwin P Bottinger; Olle Melander; Marju Orho-Melander; Ruth J F Loos; Stefano Duga; Piera Angelica Merlini; Martin Farrall; Anuj Goel; Rosanna Asselta; Domenico Girelli; Nicola Martinelli; Svati H Shah; William E Kraus; Mingyao Li; Daniel J Rader; Muredach P Reilly; Ruth McPherson; Hugh Watkins; Diego Ardissino; Qunyuan Zhang; Judy Wang; Michael Y Tsai; Herman A Taylor; Adolfo Correa; Michael E Griswold; Leslie A Lange; John M Starr; Igor Rudan; Gudny Eiriksdottir; Lenore J Launer; Jose M Ordovas; Daniel Levy; Y-D Ida Chen; Alexander P Reiner; Caroline Hayward; Ozren Polasek; Ian J Deary; Ingrid B Borecki; Yongmei Liu; Vilmundur Gudnason; James G Wilson; Cornelia M van Duijn; Charles Kooperberg; Stephen S Rich; Bruce M Psaty; Jerome I Rotter; Christopher J O'Donnell; Kenneth Rice; Eric Boerwinkle; Sekar Kathiresan; L Adrienne Cupples
Journal:  Am J Hum Genet       Date:  2014-02-06       Impact factor: 11.025

9.  A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase.

Authors:  Zhiyao Fu; Abdul B Abou-Samra; Ren Zhang
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

Review 10.  Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.

Authors:  Kelli L Sylvers-Davie; Brandon S J Davies
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-08-02       Impact factor: 5.900

View more
  6 in total

Review 1.  Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.

Authors:  Bai-Hui Zhang; Fan Yin; Ya-Nan Qiao; Shou-Dong Guo
Journal:  Front Mol Biosci       Date:  2022-05-25

2.  Effect of physical activity in a weight loss program on circulating total ANGPTL8 concentrations in northern Americans with obesity: A prospective randomized controlled trial.

Authors:  Chia-Po Fu; Elizabeth E Oczypok; Hira Ali; James P DeLany; Valerie L Reeves; Ruey-Feng Chang; Erin E Kershaw
Journal:  Nutr Metab Cardiovasc Dis       Date:  2022-04-12       Impact factor: 4.666

3.  The Lipid Energy Model: Reimagining Lipoprotein Function in the Context of Carbohydrate-Restricted Diets.

Authors:  Nicholas G Norwitz; Adrian Soto-Mota; Bob Kaplan; David S Ludwig; Matthew Budoff; Anatol Kontush; David Feldman
Journal:  Metabolites       Date:  2022-05-20

4.  An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.

Authors:  Deepa Balasubramaniam; Oliver Schroeder; Anna M Russell; Jonathan R Fitchett; Aaron K Austin; Thomas P Beyer; Yan Q Chen; Jonathan W Day; Mariam Ehsani; Aik Roy Heng; Eugene Y Zhen; Julian Davies; Wolfgang Glaesner; Bryan E Jones; Robert W Siegel; Yue-Wei Qian; Robert J Konrad
Journal:  J Lipid Res       Date:  2022-03-17       Impact factor: 6.676

5.  The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway.

Authors:  Simone Bini; Valeria Pecce; Alessia Di Costanzo; Luca Polito; Ameneh Ghadiri; Ilenia Minicocci; Federica Tambaro; Stella Covino; Marcello Arca; Laura D'Erasmo
Journal:  Biomolecules       Date:  2022-04-16

6.  Correlation between betatrophin/angiogenin-likeprotein3/lipoprotein lipase pathway and severity of coronary artery disease in Kazakh patients with coronary heart disease.

Authors:  Lian Qin; Rena Rehemuding; Aikeliyaer Ainiwaer; Xiang Ma
Journal:  World J Clin Cases       Date:  2022-03-06       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.